This inventor holds 6 USPTO granted patents and 2 published patent applications. Top assignees: Institute for Cancer Research, Fox Chase Cancer Center, Hoffmann-La Roche Inc.. Active years: 1990-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Princeton, NJ (US) (1990 - 2017)
- Philadelphia, PA (US) (2021 - 2022)
Company Filing History:
3 out of 69 
2 out of 81 
1 out of 5,024 
Years Active: 1990-2022
Title: **The Innovative Journey of Anna Marie Skalka**
Introduction
Anna Marie Skalka, a prominent inventor based in Princeton, NJ, has made significant contributions to the field of medical science, particularly in combating human immunodeficiency virus (HIV). With a total of six patents to her name, her work reflects her dedication to innovative research and the advancement of healthcare solutions.
Latest Patents
Skalka's latest patents focus on the inhibitors of HIV-1 integrase multimerization. The disclosures related to these patents generally involve compounds, compositions, and methods for treating HIV infections. Specifically, she has developed novel inhibitors of HIV-1 integrase that can be used to create pharmaceutical compositions aimed at managing the HIV epidemic. The methods outlined in her patents provide valuable insights into the treatment of HIV infection, highlighting her role as a trailblazer in this critical area of research.
Career Highlights
Throughout her career, Anna Marie Skalka has been associated with esteemed institutions such as the Institute for Cancer Research and the Fox Chase Cancer Center. Her work in these organizations has not only enhanced her expertise in virology and cancer research but has also allowed her to contribute to groundbreaking advancements in therapeutic methodologies.
Collaborations
In her journey, Skalka has collaborated with notable colleagues including Mark D Andrake and George W Merkel. These collaborations have enriched her research, fostering an environment of innovative thinking and shared knowledge that is crucial for the development of effective treatments.
Conclusion
Anna Marie Skalka's contributions to the field of HIV research exemplify the impact that dedicated inventors can have on global health. Her patents serve not only as a testament to her innovative spirit but also as a beacon of hope for those affected by HIV. As her work continues to evolve, it will undoubtedly inspire future generations of researchers and inventors in the fight against infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile